![Labcorp Drug Development on Twitter: "Not all kits are created equal – find out why investigators prefer Covance kits. #pharmadevelopment https://t.co/9kPqeZ69Ez https://t.co/0Av16SMv4j" / Twitter Labcorp Drug Development on Twitter: "Not all kits are created equal – find out why investigators prefer Covance kits. #pharmadevelopment https://t.co/9kPqeZ69Ez https://t.co/0Av16SMv4j" / Twitter](https://pbs.twimg.com/media/DQxpmkVVAAA0SDq.jpg:large)
Labcorp Drug Development on Twitter: "Not all kits are created equal – find out why investigators prefer Covance kits. #pharmadevelopment https://t.co/9kPqeZ69Ez https://t.co/0Av16SMv4j" / Twitter
identify a backup in case the primary lab experiences delayed turnaround times in providing results.
![Vaccines | Free Full-Text | A Clinical Insight on New Discovered Molecules and Repurposed Drugs for the Treatment of COVID-19 Vaccines | Free Full-Text | A Clinical Insight on New Discovered Molecules and Repurposed Drugs for the Treatment of COVID-19](https://pub.mdpi-res.com/vaccines/vaccines-11-00332/article_deploy/html/images/vaccines-11-00332-ag.png?1676004489)
Vaccines | Free Full-Text | A Clinical Insight on New Discovered Molecules and Repurposed Drugs for the Treatment of COVID-19
![LabCorp and Envigo sign innovative agreement to expand Covance's nonclinical drug development capabilities and create an independent research models provider LabCorp and Envigo sign innovative agreement to expand Covance's nonclinical drug development capabilities and create an independent research models provider](https://www.inotivco.com/hubfs/images/corporate/envigo-covance-infographic.png)